On November 14, the European Commission approved AstraZeneca and Bristol-Myers Squibb’s Forxiga (dapagliflozin) for type 2 diabetes throughout the European Union...

Visiting your healthcare team? Kerri Sparling highlights the right questions to ask.

In May, Johnson & Johnson submitted its SGLT-2 inhibitor canagliflozin for approval in the US. On average, the FDA takes about ten months to review applications for...

As noted in new now next in diaTribe #37, Novo Nordisk announced in October 2011 that it had submitted its two new “next-generation” insulin products for approval in the...

(S)he said what?!?

The giant Consumer Electronics Show, held each January in Las Vegas, had a variety of devices relevant to diabetes and obesity this year. Media buzz surrounded the...

Two well-known endocrinologists debated the merits of inhaled insulin in the February edition of Diabetes Care.

Click to learn exciting news on the artificial pancreas, faster insulins, and the results of the much-anticipated ORIGIN trial.

In September, Medtronic and Bayer announced that Bayer's Contour Next Link meter became available to patients ordering new Medtronic Paradigm Revel insulin pumps and...

Kelly on a heated day at the FDA and why a new drug class could bring diabetes patients, doctors, and educators closer to personalized therapy.

In March 2013, Novo Nordisk launched Tresiba (insulin degludec) , its new once-daily basal insulin for type 1 and type 2 diabetes, in the UK and Denmark. Tresiba will be...

Highlights from Maryland's back-to-back meetings.

In January, the American Heart Association and American Diabetes Association published a statement giving their joint recommendations for the primary prevention of CVD...

(S)he said what!?

DiabetesSisters hosted the 2013 Weekend for Women Conference in San Francisco on October 4-6, 2013. Our own Editor-in-Chief Kelly Close and Co-Managing Editor Adam Brown...

On January 20, Tandem announced an expanded recall on its t:slim insulin pump cartridges – the affected cartridges ( listed here ) may be at risk of insulin leaking...

The 73rd Scientific Sessions of the American Diabetes Association will be held from June 21-25 in Chicago. The five-day conference will feature hundreds of presentations...

All you need to know about diabetic neuropathy - the facts, prevention, and treatment.

On September 12, First Lady Michelle Obama, actress Eva Longoria, and the Partnership for a Healthier America launched a campaign to encourage Americans to drink more...

On January 21, Novo Nordisk announced the launch of the NovoPen Echo in the US. This is the first and only pen device available in the US with half-unit dosing and a...